Drugs / Pneumovax 23TM
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01767402 Comparator | Oct 2003 → Nov 2004 | pneumococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pneumovax 23TM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01767402 ↗ |
| Modality | Vaccine | “comparator vaccine (Pneumovax 23TM)” NCT01767402 ↗ |
| Route | Intramuscular | “One dose of Pneumovax 23TM vaccine administered intramuscularly in the deltoid region of the right arm at month 0.” NCT01767402 ↗ |